U.S. Contrast Media Market Size, Share & Trends Analysis Report by Type (Gadolinium, Iodinated), by Application (Cardiovascular, Neurological Disorders), by Modality (MRI, X-ray/CT Scan), and Segment Forecasts, 2022-2030

The U.S. contrast media market is anticipated to reach USD3.36 billion by 2030, registering a CAGR of 4.12% over the forecast period. The increasing burden of chronic diseases is creating a demand for diagnostic imaging procedures, which, in turn, is driving the market growth. Imaging tests, such as MRI, have become an integral part of the diagnosis for most diseases, and large-scale penetration of imaging technology in healthcare has increased the demand for contrast media in the U.S. market. Chronic diseases, such as cancer and diabetes, are rapidly becoming a major public health concern and are among the leading causes of death across the U.S., resulting in the need for early diagnostic tools and effective treatment options.

Hence, the increasing prevalence of complex comorbidities and long-term diseases is one of the major drivers of imaging tests and contrast agents; thus, contributing to the market growth. The COVID-19 outbreak had a negative impact on the market due to decreased patient visits to hospitals. Many radiology departments experienced a rapid decline in imaging case volume. However, many states in the U.S. have begun to reopen their economies; however, it will take time for the utilization rate of contrast media to reach pre-pandemic levels. In addition, with the launch of COVID-19 vaccines and ease in restrictions, the import and export of raw materials have resumed. This, in turn, therefore, is expected to boost the market growth over the forecast period.

U.S. Contrast Media Market Report Highlights

Imaging tests, such as MRI, have become an integral part of the diagnosis for most diseases, and large-scale penetration of imaging technology in healthcare has increased the demand for contrast media in the U.S. market
The iodinated type segment accounted for the largest market share in 2021 on account of excellent radio-opacity and low toxicity of iodinated contrast media than other agents
The X-ray/CT scan modality segment held the largest revenue share in 2021. Wide acceptance and cost-efficiency of X-ray/CT modality boost the adoption of contrast agents for this modality
The rising demand for imaging procedures has resulted in extensive R&D activities by contrast media manufacturers to launch novel products in the market and to get approved for new indications
For instance, in 2021, Bracco got the U.S. FDA approval for 20-vial pack configuration of Lumason, which is an ultrasound contrast media agent

This product will be delivered within 1-3 business days.

Frequently Asked Questions about the U.S. Contrast Media Market

What is the estimated value of the U.S. Contrast Media Market?

The U.S. Contrast Media Market was estimated to be valued at $2.43 Billion in 2022.

What is the growth rate of the U.S. Contrast Media Market?

The growth rate of the U.S. Contrast Media Market is 4.1%, with an estimated value of $3.36 Billion by 2030.

What is the forecasted size of the U.S. Contrast Media Market?

The U.S. Contrast Media Market is estimated to be worth $3.36 Billion by 2030.

Who are the key companies in the U.S. Contrast Media Market?

Key companies in the U.S. Contrast Media Market include Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, Inc, Bracco Diagnostic Inc, Trivitron Healthcare, Nano Therapeutics Pvt. Ltd. and Cmc Contrast Ab (Ascelia Pharma Ab).

Report Attribute	Details
No. of Pages	94
Published	March 2022
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 2.43 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.36 Billion
Compound Annual Growth Rate	4.1%
Regions Covered	United States
No. of Companies Mentioned	9

Chapter 1 Methodology and Scope

1.1 Market Segmentation and Scope
1.1.1 Type
1.1.2 Modality
1.1.3 Application
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details OF Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 U.S. Contrast Media Market Variables, Trends & Scope

3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Beheaviour Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End-users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increase in the prevalence of long-term diseases and complex comorbidities
3.5.1.2 Technological advancements
3.5.1.3 Label expansions (competitive strategies)
3.5.2 Market RestraintsAnalysis
3.5.2.1 Rising concern about the risk of gadolinium retention in the brain
3.6 U.S. Contrast Media: Market Analysis Tools
3.6.1 Industry Analysis-PORTER’S
3.6.2 Swot Analysis, BY Pest
3.7 Impact of COVID-19 on Market & Post Pandemic Insights
3.8 Pipeline Analysis
3.9 Major Deals and Strategic Alliances Analysis
3.10 Market Entry Strategies
3.11 Regulatory Framework
3.12 Reimbursement Framework
3.13 Industry Challenges

Chapter 4 U.S. Contrast Media Market: Segment Analysis, By Type, 2018-2030 (USD Million)

4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 U.S. Contrast Media Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.5.1 Microbubble Contrast Media
4.5.1.1 Microbubble contrast media market, 2018-2030 (USD Million)
4.5.2 Gadolinium-based contrast media
4.5.2.1 Gadolinium-based contrast media market, 2018-2030 (USD Million)
4.5.3 Iodinated contrast media
4.5.3.1 Iodinated contrast media market, 2018-2030 (USD Million)
4.5.4 Barium-Based contrast media
4.5.4.1 Barium-based contrast media market, 2018-2030 (USD Million)

Chapter 5 U.S. Contrast Media Market: Segment Analysis, By Application, 2018-2030 (USD Million)

5.1 Definition and Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 U.S. Contrast Media Market, by Application, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
5.5.1 Cardiovascular
5.5.1.1 Cardiovascular market, 2018-2030 (USD Million)
5.5.2 Neurological Disorders
5.5.2.1 Neurological disorders market, 2018-2030 (USD Million)
5.5.3 Gastrointestinal Disorders
5.5.3.1 Gastrointestinal disorders market, 2018-2030 (USD Million)
5.5.4 Cancer
5.5.4.1 Cancer market, 2018-2030 (USD Million)
5.5.5 Nephrologica Disorders
5.5.5.1 Nephrological disorders market, 2018-2030 (USD Million)
5.5.6 Musculoskeletal Disorders
5.5.6.1 Musculoskeletal disorders market, 2018-2030 (USD Million)
5.5.7 Others
5.5.7.1 Others market, 2018-2030 (USD Million)

Chapter 6 U.S. Contrast Media Market: Segment Analysis, By Modality, 2018-2030 (USD Million)

6.1 Definition and Scope
6.2 Modality Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 U.S. Contrast Media Market, by Modality, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.5.1 Ultrasound
6.5.1.1 Ultrasound Market, 2018-2030 (USD Million)
6.5.2 Magnetic Resonance Imaging (MRI)
6.5.2.1 Magnetic Resonance Imaging (MRI) market, 2018-2030 (USD Million)
6.5.3 X-RAY/Computed Tomograph
6.5.3.1 X-ray/Computed Tomography Market, 2018-2030 (USD Million)

Chapter 7 U.S. Contrast Media Market-Competitive Analysis

7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Company Profiles
7.2.1 BAYER AG
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 GE HEALTHCARE
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 GUERBET
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 LANTHEUS MEDICAL IMAGING, INC
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 BRACCO DIAGNOSTIC INC
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 TRIVITRON HEALTHCARE
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 NANO THERAPEUTICS PVT. LTD.
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 IMAX DIAGNOSTIC IMAGING
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.2 Strategic initiatives
7.2.9 CMC CONTRAST AB (ASCELIA PHARMA AB)
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Major ultrasound contrast media agents
Table 4. Gadolinium-based contrast media
Table 5. Iodinated contrast media
Table 6. Barium-based contrast media
Table 7. Ultrasound
Table 8. MRI
Table 9. X-ray/CT

List of Figures

Fig 1. U.S. contrast media Market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. QFD modeling for market share assessment
Fig 8. Market formulation & validation
Fig 9. Market outlook (2021)
Fig 10. Segment outlook
Fig 11. Strategy framework
Fig 12. Penetration & growth prospect mapping
Fig 13. Consumer behavior analysis
Fig 14. Market driver relevance analysis (Current & future impact)
Fig 15. Market restraint relevance analysis (Current & future impact)
Fig 16. Porter’s five forces analysis
Fig 17. SWOT analysis, by factor (political & legal, economic and technological)
Fig 18. U.S. contrast media market: Type movement analysis
Fig 19. Segment dashboard
Fig 20. U.S. contrast media market type outlook: Key takeaways
Fig 21. Microbubble contrast media market, 2018 - 2030 (USD Million)
Fig 22. Gadolinium-based contrast media market, 2018 - 2030 (USD Million)
Fig 23. Iodinated contrast media market, 2018 - 2030 (USD Million)
Fig 24. Barium-based contrast media market, 2018 - 2030 (USD Million)
Fig 25. U.S. contrast media Market: Application movement analysis
Fig 26. Segment dashboard
Fig 27. U.S. contrast media market application outlook: Key takeaways
Fig 28. Cardiovascular conditions market, 2018 - 2030 (USD Million)
Fig 29. Neurological disorders market, 2018 - 2030 (USD Million)
Fig 30. Gastrointestinal disorders market, 2018 - 2030 (USD Million)
Fig 31. Cancer market, 2018 - 2030 (USD Million)
Fig 32. Nephrological disorders market, 2018 - 2030 (USD Million)
Fig 33. Musculoskeletal disorders market, 2018 - 2030 (USD Million)
Fig 34. Others market, 2018 - 2030 (USD Million)
Fig 35. U.S. contrast media market: Modality movement analysis
Fig 36. Segment dashboard
Fig 37. U.S. contrast media market modality outlook: Key takeaways
Fig 38. Ultrasound market, 2018 - 2030 (USD Million)
Fig 39. Magnetic Resonance Imaging (MRI) market, 2018 - 2030 (USD Million)
Fig 40. X-ray/Computed Tomography market, 2018 - 2030 (USD Million)